Pharmaceutical giant Pfizer (NYSE: PFE) stands out in this context. The company currently offers a mouthwatering 5.7% dividend yield-- the highest among major drug manufacturers and one of the ...

We came across a bullish thesis on Pfizer Inc. (PFE) on gurufocus by Akim Guerreiro. In this article we will summarize the bulls’ thesis on PFE. Pfizer Inc. share was trading at $29.16 as of ...

NEW YORK, Sept 14 (Reuters) - Pfizer (PFE.N), opens new tab is trying to increase doctor awareness of and testing for a rare lung cancer mutation to help boost use of its drug Braftovi ...

Journalist Alex Berenson said Meta CEO Mark Zuckerberg’s admission that his company, Facebook, was pressured by the Biden-Harris administration to censor Americans, particularly regarding COVID ...

To start, according to Pfizer’s launch announcement Tuesday, the platform’s services will focus on providing access to treatments for common conditions like migraine, COVID-19 and the flu as ...

Struggling with plunging demand for its Covid products, Pfizer Inc. has a new plan to reach potential customers: Using telehealth to sell drugs straight to patients. The company launched a website ...

Pfizer (NYSE:PFE) has announced PfizerForAll, a new website that will offer vaccines, medical tests and medications delivered at home. PfizerForAll is designed for patients with migraine, COVID-19 ...

Struggling with plunging demand for its Covid products, Pfizer Inc. has a new plan to reach potential customers: Cutting out middleman and selling drugs straight to patients. The company launched ...

Aug 27 (Reuters) - Pfizer Inc (PFE.N), opens new tab is launching a new website to promote and improve access to its health care offerings for migraine and respiratory illnesses. The drugmaker ...

Flagship Pioneering and Pfizer have added Quotient into their 10-program partnership, inking a deal to discover new targets for two programs in cardiovascular and renal diseases. The deal fits ...

Through its Ignite program, Pfizer partners with biotechs to help them advance new drugs from preclinical development all the way to market.Ignite mainly focuses on oncology, inflammation and ...

One of Pfizer's vaccine programs failed to demonstrate its utility. Its competitors had the same issue with their programs. However, this particular candidate was especially important to Pfizer.